![Thomas Wei](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Wei
Directeur Technique/Scientifique/R&D chez
AURINIA PHARMACEUTICALS INC.
Profil
Mr. Thomas Wei is a Chief Scientific Officer at Tang Capital Acquisition Corp., a Chief Scientific Officer at Aurinia Pharmaceuticals, Inc. and a Managing Director at Tang Capital Management LLC.
Mr. Wei was previously employed as a Chief Scientific Officer by Odonate Therapeutics, Inc., an Equity Analyst by Jefferies LLC, a Managing Director & Principal by U.S.
Bancorp Piper Jaffray Ventures, a Research Associate by Deutsche Bank Securities, Inc., an Analyst by Adams Harkness & Hill Investment Banking, and a Managing Director by Piper Jaffray & Co. (Broker).
He received his undergraduate degree from Harvard University and an MBA from the University of Oxford.
Postes actifs de Thomas Wei
| Sociétés | Poste | Début |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 21/03/2026 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Gestionnaire de Portefeuille-Actions | 01/01/2015 |
Anciens postes connus de Thomas Wei
| Sociétés | Poste | Fin |
|---|---|---|
| ODONATE, INC. | Directeur Technique/Scientifique/R&D | 01/12/2021 |
U.S. Bancorp Piper Jaffray Ventures
 U.S. Bancorp Piper Jaffray Ventures Investment ManagersFinance Piper Jaffray Ventures focuses on emerging-growth companies in medical devices, healthcare services and technology. | Corporate Officer/Principal | 30/09/2009 |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 15/08/2009 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Adams Harkness & Hill Investment Banking
 Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Corporate Officer/Principal | 30/04/2000 |
Formation de Thomas Wei
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Finance |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adams Harkness & Hill Investment Banking
Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Finance |
U.S. Bancorp Piper Jaffray Ventures
U.S. Bancorp Piper Jaffray Ventures Investment ManagersFinance Piper Jaffray Ventures focuses on emerging-growth companies in medical devices, healthcare services and technology. | Finance |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Odonate, Inc.
 Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
